TBI (Traumatic Brain Injury) Clinical Trial
Official title:
Self-Advocacy for Independent Life (SAIL) After Traumatic Brain Injury
Verified date | July 2020 |
Source | Craig Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Traumatic brain injury (TBI) has been conceptualized as a chronic health condition, warranting self-advocacy for health management services across the lifespan. Successful self-advocacy requires a combination of cognitive and communication skills (problem solving, organization, negotiation, etc), which may be impaired following TBI. This project focuses on developing and testing the efficacy of an intervention to enhance self-advocacy skills in individuals who have sustained TBI. This two-arm, randomized controlled trial will include approximately 74 participants, recruited in 4 waves of approximately 18-20 per wave, with each wave recruited from a different geographic area of the state. The primary hypothesis states that participants receiving the treatment intervention will demonstrate significantly greater improvements in self-advocacy beliefs (SAS) from baseline to post-intervention as compared to participants in the control group. Treatment will consist of interactive 4-session workshops along with 2 booster phone calls. Control participants will receive a copy of a self-advocacy workbook after all assessments are completed. Baseline, post-treatment and two follow-up assessments will take place.
Status | Completed |
Enrollment | 76 |
Est. completion date | March 31, 2020 |
Est. primary completion date | March 31, 2020 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Documented TBI due to an external mechanical force - Received inpatient or outpatient rehabilitation for TBI - At least 9 months post TBI - Able to travel independently in the community - Able to attend intervention sessions Exclusion Criteria: - Unable to read or speak English well enouth to complete assessments and actively participate in study intervention - Currently in inpatient TBI rehabilitation - Previously participated in a SAIL program - Participating in another research trial - Unable to perform neuropsychological baseline assessment - Score of 30 or above on GSES |
Country | Name | City | State |
---|---|---|---|
United States | Craig Hospital | Englewood | Colorado |
Lead Sponsor | Collaborator |
---|---|
Craig Hospital |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Self-Advocacy Scale (SAS) | The Self-Advocacy Scale (SAS) is an eight-item 1-4 Likert rating scale (1 = not confident to 4 = very confident), conceptualized as a domain specific self-efficacy scale. The SAS is designed to measure an individual's current beliefs about his or her ability to produce desired self-advocacy outcomes. Scores range from 8 to 32 with higher scores indicative of better self-advocacy skills. | Change in SAS score from Baseline to 11 weeks (immediately post-tx) | |
Primary | Self-Advocacy Scale (SAS) | The Self-Advocacy Scale (SAS) is an eight-item 1-4 Likert rating scale (1 = not confident to 4 = very confident), conceptualized as a domain specific self-efficacy scale. The SAS is designed to measure an individual's current beliefs about his or her ability to produce desired self-advocacy outcomes. Scores range from 8 to 32 with higher scores indicative of better self-advocacy skills. | Change in SAS score from Baseline to 17 weeks (6 weeks post-tx) | |
Primary | Self-Advocacy Scale (SAS) | The Self-Advocacy Scale (SAS) is an eight-item 1-4 Likert rating scale (1 = not confident to 4 = very confident), conceptualized as a domain specific self-efficacy scale. The SAS is designed to measure an individual's current beliefs about his or her ability to produce desired self-advocacy outcomes. Scores range from 8 to 32 with higher scores indicative of better self-advocacy skills. | Change in SAS score from Baseline to 23 weeks (12 weeks post-tx) | |
Secondary | Personal Advocacy Activity Scale (PAAS) | The Personal Advocacy Activity Scale (PAAS) is a 12-item self-rating of personal advocacy behaviors. Participants respond to each item by indicating how frequently they perform each activity, "Not at all", "1 - 4 times", or "5 or more times". Scores range from 12 to 36 with higher scores indicating more personal advocacy behavior. | Change in PAAS score from Baseline to 11 weeks (immediately post-tx) | |
Secondary | Personal Advocacy Activity Scale (PAAS) | The Personal Advocacy Activity Scale (PAAS) is a 12-item self-rating of personal advocacy behaviors. Participants respond to each item by indicating how frequently they perform each activity, "Not at all", "1 - 4 times", or "5 or more times". Scores range from 12 to 36 with higher scores indicating more personal advocacy behavior. | Change in PAAS score from Baseline to 17 weeks (6 weeks post-tx) | |
Secondary | Personal Advocacy Activity Scale (PAAS) | The Personal Advocacy Activity Scale (PAAS) is a 12-item self-rating of personal advocacy behaviors. Participants respond to each item by indicating how frequently they perform each activity, "Not at all", "1 - 4 times", or "5 or more times". Scores range from 12 to 36 with higher scores indicating more personal advocacy behavior. | Change in PAAS score from Baseline to 23 weeks (12 weeks post-tx) | |
Secondary | General Self Efficacy Scale (GSES) | General Self Efficacy Scale (GSES) is a 10-item Likert rating scale assessing beliefs about one's ability to cope with various demands in life, a core component of self-advocacy.The GSES produces a single score ranging from 10 to 40, with higher scores indicating greater general self-efficacy. | Change in GSES score from Baseline to 11 weeks (immediately post-tx) | |
Secondary | General Self Efficacy Scale (GSES) | General Self Efficacy Scale (GSES) is a 10-item Likert rating scale assessing beliefs about one's ability to cope with various demands in life, a core component of self-advocacy.The GSES produces a single score ranging from 10 to 40, with higher scores indicating greater general self-efficacy. | Change in GSES score from Baseline to 17 weeks (6 weeks post-tx) | |
Secondary | General Self Efficacy Scale (GSES) | General Self Efficacy Scale (GSES) is a 10-item Likert rating scale assessing beliefs about one's ability to cope with various demands in life, a core component of self-advocacy.The GSES produces a single score ranging from 10 to 40, with higher scores indicating greater general self-efficacy. | Change in GSES score from Baseline to 23 weeks (12 weeks post-tx) | |
Secondary | Satisfaction With Life Scale (SWLS) | The Satisfaction with Life Scale (SWLS) is a subjective, five-item 1-7 Likert rating scale measuring global life satisfaction - a cognitive self-assessment of quality of life. Scores range from 5 to 35 with higher scores indicative of greater life satisfaction | Change in SWLS score from Baseline to 11 weeks (immediately post-tx) | |
Secondary | Satisfaction With Life Scale (SWLS) | The Satisfaction with Life Scale (SWLS) is a subjective, five-item 1-7 Likert rating scale measuring global life satisfaction - a cognitive self-assessment of quality of life. Scores range from 5 to 35 with higher scores indicative of greater life satisfaction | Change in SWLS score from Baseline to 17 weeks (6 weeks post-tx) | |
Secondary | Satisfaction With Life Scale (SWLS) | The Satisfaction with Life Scale (SWLS) is a subjective, five-item 1-7 Likert rating scale measuring global life satisfaction - a cognitive self-assessment of quality of life. Scores range from 5 to 35 with higher scores indicative of greater life satisfaction | Change in SWLS score from Baseline to 23 weeks (12 weeks post-tx) | |
Secondary | Flourishing Scale (FS) | The Flourishing Scale (FS) is a brief eight-item, self-rated, 1-7 point Likert scale measure of self-perceived success in areas such as social relationships, self-esteem, and purpose in life. Scores range from 5 to 35 with higher scores indicating better self-perceived success. | Change in total Flourishing Scale score from Baseline to 11 weeks (immediately post-tx) | |
Secondary | Flourishing Scale (FS) | The Flourishing Scale (FS) is a brief eight-item, self-rated, 1-7 point Likert scale measure of self-perceived success in areas such as social relationships, self-esteem, and purpose in life. Scores range from 5 to 35 with higher scores indicating better self-perceived success. | Change in total Flourishing Scale from Baseline to 17 weeks (6 weeks post-tx) | |
Secondary | Flourishing Scale (FS) | The Flourishing Scale (FS) is a brief eight-item, self-rated, 1-7 point Likert scale measure of self-perceived success in areas such as social relationships, self-esteem, and purpose in life. Scores range from 5 to 35 with higher scores indicating better self-perceived success. | Change in total Flourishing Scale score from Baseline to 23 weeks (12 weeks post-tx) | |
Secondary | Participation Assessment with Recombined Tools-Objective (PART-O) | Objective measure of participation in society | Change in PART-O score from Baseline to 11 weeks (immediately post-tx) | |
Secondary | Participation Assessment with Recombined Tools-Objective (PART-O) | Objective measure of participation in society | Change in PART-O score from Baseline to 17 weeks (6 weeks post-tx) | |
Secondary | Participation Assessment with Recombined Tools-Objective (PART-O) | Objective measure of participation in society | Change in PART-O score from Baseline to 23 weeks (12 weeks post-tx) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04526639 -
VR Cognitive Rehabiliation for Pediatric TBI
|
N/A | |
Recruiting |
NCT05943756 -
Evaluation of Well-being Interventions in Adults With TBI
|
N/A | |
Completed |
NCT01339702 -
The EPIC Project: Impact of Implementing the EMS Traumatic Brain Injury Treatment Guidelines
|
||
Completed |
NCT00760734 -
Hyperbaric Oxygen Therapy (HBOT) in Chronic Traumatic Brain Injury (TBI)/Post Concussion Syndrome (PCS) and TBI/Post-Traumatic Stress Disorder (PTSD)
|
Phase 1 | |
Not yet recruiting |
NCT06024122 -
Brain Development in Young Children Following Mild Traumatic Brain Injury - Pilot Study
|
||
Completed |
NCT03896789 -
Pediatric Guideline Adherence and Outcomes- Argentina
|
N/A | |
Completed |
NCT03225768 -
Guided Training for People With Cognitive Impairment
|
N/A | |
Completed |
NCT04590911 -
Effectiveness of Multimodal Cognitive Rehabilitation for Traumatic Brain Injury Sustained During Older Adulthood
|
N/A | |
Recruiting |
NCT04121780 -
Growth Hormone Replacement Therapy for Retried Professional Football Players
|
Phase 2 | |
Completed |
NCT04776304 -
Art Therapy qEEG Study for Service Members With a Traumatic Brain Injury and Posttraumatic Stress Symptoms
|
N/A | |
Completed |
NCT00409058 -
Teen Online Problem Solving (TOPS) - An Online Intervention Following TBI
|
N/A | |
Completed |
NCT00205491 -
Pharmacological Intervention in Depression After Traumatic Brain Injury
|
Phase 4 | |
Completed |
NCT03490110 -
Brain Markers of Improvements in Cognitive Functioning
|
N/A | |
Active, not recruiting |
NCT02525432 -
Autologous Stem Cell Study for Adult TBI (Phase 2b)
|
Phase 2 | |
Completed |
NCT02858544 -
Concussion in Motor Vehicle Accidents: The Concussion Identification Index
|
N/A | |
Completed |
NCT01728831 -
Study of Cerebral Tissue Oxygenation During Transfusion in Traumatic Brain Injury
|
N/A | |
Recruiting |
NCT06005194 -
InMotion - Telehealth Delivered Exercise Promotion to Treat Major Depression After TBI
|
N/A | |
Not yet recruiting |
NCT05340803 -
Sedation of Ventilated Traumatic Brain Injury Patients With Midazolam Alone Versus Combination With Dexmedetomidine or Magnesium Sulfate; Monitored by Ultrasonograghic Optic Nerve Sheath Diameter
|
Phase 3 | |
Recruiting |
NCT06195345 -
Individual Cerebral Hemodynamic Oxygenation Relationships (ICHOR 1)
|
||
Recruiting |
NCT04279431 -
Follow-up of mTBI Patients Discharged From the ED Using Standard Clinical Triage Including BrainScope One
|